10月06日
OTS 2024
10.06 - 10.09
加拿大，蒙特利尔
Hongene is thrilled to announce our participation in OTS 2024. The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society's mission and goals, to foster academic and industry-based research for development.
Welcome to visit our booth at #4-11. Let's discuss how Hongene's high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.
Featured Talk Session
Speaker: David Butler, Chief Technology Officer
Title: The Evolving Landscape of Oligonuecleotide Manufacturing
Date/Time: Sunday, October 6, 09:55 -10:20 a.m. EDT
Overview: The presentation emphasizes the ongoing innovation in scalable manufacturing technologies to meet the growing demand for RNA therapeutics, while addressing the product purity and environmental challenges associated with current methods.